Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

10.1002/ajh.21420

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Lai, G.G.Y., Lim, S.-T., Tao, M., Chan, A., Li, H., Quek, R.
مؤلفون آخرون:	PHARMACY
التنسيق:	مقال
منشور في:	2014
الوصول للمادة أونلاين:	http://scholarbank.nus.edu.sg/handle/10635/106106
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

The Effect of CHOP or RCHOP Chemotherapy Regiment on D-dimer Levels of Non-Hodgkin Lymphoma Patients
بواسطة: Dewi A.K., وآخرون
منشور في: (2019)

TARGETING DNA DAMAGE RESPONSE KINASES TO IMPROVE CHEMOTHERAPY EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA
بواسطة: ALLISON SI-YU CHAN
منشور في: (2023)

Primary response and saefty of 90yitrium ibritumomab tiuxetan followed by combined chemotherapy of cyclophosphamide, doxorubicin, vincristine, and prednisolone for diffuse large B-Cell lymphoma
بواسطة: Krittika Tanyasaensook
منشور في: (2010)

Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres
بواسطة: Wong, M., وآخرون
منشور في: (2016)

The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study
بواسطة: Thungthong P.
منشور في: (2023)

Transient adrenal insufficiency in diffuse large B cell lymphoma patients after chemotherapy with short-course, high-dose corticosteroids
بواسطة: Weerapat Owattanapanich, وآخرون
منشور في: (2019)

Breakthrough febrile neutropenia and associated complications among elderly cancer patients receiving myelosuppressive chemotherapy for solid tumors and lymphomas
بواسطة: Chan, A., وآخرون
منشور في: (2014)

Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients
بواسطة: Chan, A., وآخرون
منشور في: (2014)

Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
بواسطة: Zeng, Qun, وآخرون
منشور في: (2023)

Anterior panhypopituitarism in diffuse large B-cell stage IV lymphoma
بواسطة: Valeros, K.A., وآخرون
منشور في: (2016)

The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand
بواسطة: P. Pimsi, وآخرون
منشور في: (2019)

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma
بواسطة: Mori, S., وآخرون
منشور في: (2014)

Febrile neutropenia after chemotherapy in patients with non-hematologic malignancies
بواسطة: Narin Voravud, وآخرون
منشور في: (2006)

Angiocentric T-cell lymphoma of the pancreas presenting as late-onset diabetes mellitus with diabetic retinopathy
بواسطة: Sanya Sukpanichnant, وآخرون
منشور في: (2018)

Routine primary prophylaxis for febrile neutropenia with biosimilar granulocyte colony-stimulating factor (nivestim) or pegfilgrastim is cost effective in non-Hodgkin lymphoma patients undergoing curative-intent R-CHOP chemotherapy
بواسطة: Wang X.J., وآخرون
منشور في: (2018)

Breakthrough febrile neutropenia and associated complications in non-Hodgkin's lymphoma patients receiving pegfilgrastim
بواسطة: Ng, J.H., وآخرون
منشور في: (2014)

Modulators of rituximab-induced complement-dependent cytotoxicity in diffuse large B-cell lymphoma
بواسطة: Ong, Charmaine Zi Yan
منشور في: (2021)

Changes in etiologic microorganisms in Thai patients with chemotherapy-induced neutropenia and fever
بواسطة: Chonticha Auesomwang, وآخرون
منشور في: (2019)

F-18 FDG uptake in hemorrhoids in a patient with diffuse large B-cell lymphoma
بواسطة: Tanyaluck Thientunyakit, وآخرون
منشور في: (2018)

Identification of molecular factors mediating therapeutic resistance in diffuse large B-cell lymphoma (DLBCL)
بواسطة: Peng, Chenchen
منشور في: (2024)

The Contribution of MYC and PLK1 Expression to Proliferative Capacity in Diffuse Large B-Cell Lymphoma
بواسطة: Ming Liang Oon, وآخرون
منشور في: (2020)

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients
بواسطة: Pera, B, وآخرون
منشور في: (2020)

Ekspresi EBNA-1 pada diffuse large B cell lymphoma serta Small lymphocytic lymphoma tipe nodal dan ekstranodal
بواسطة: Perpustakaan UGM, i-lib
منشور في: (2006)

Costs associated with febrile neutropenia in solid tumor and lymphoma patients - An observational study in Singapore
بواسطة: Wang X.J., وآخرون
منشور في: (2018)

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
بواسطة: Liu, Min, وآخرون
منشور في: (2024)

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
بواسطة: Ong, Shin Yeu, وآخرون
منشور في: (2021)

Late-onset intrascleral dissemination of Pseudomonas aeruginosa scleritis following pterygium excision
بواسطة: Somsanguan Ausayakhun, وآخرون
منشور في: (2019)

Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy
بواسطة: Chen, C., وآخرون
منشور في: (2014)

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
بواسطة: Smedby K.E., وآخرون
منشور في: (2018)

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
بواسطة: Kizhakeyil, Atish, وآخرون
منشور في: (2022)

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: A multicentre experience
بواسطة: Andrew R. Rezvani, وآخرون
منشور في: (2018)

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era
بواسطة: Lim, R.M.H., وآخرون
منشور في: (2021)

HUBUNGAN RASIO NETROFIL LIMFOSIT DENGAN RESPON TERAPI PASIEN DIFFUSE LARGE B-CELL LYMPHOMA YANG MENJALANI KEMOTERAPI RCHOP Penelitian Analisis Observasional Kohort Retrospektif Periode Januari 2015 sampai dengan Juli 2018 Poli Onkologi Satu Atap Divisi Hematologi Onkologi Medik Departemen Penyakit Dalam RSUD Dr. Soetomo Surabaya
بواسطة: SHEILA NALIA, NIM011218026315
منشور في: (2018)

Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group
بواسطة: Thanhakun R.
منشور في: (2023)

One patient, two uncommon B-cell neoplasms: Solitary plasmacytoma following complete remission from intravascular large B-cell lymphoma involving central nervous system
بواسطة: Lee, J, وآخرون
منشور في: (2020)

Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results
بواسطة: Ong, Seeu Si, وآخرون
منشور في: (2023)

Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy
بواسطة: Chan, A., وآخرون
منشور في: (2014)

EKSPRESI P53 DAN Ki 67 PADA DIFFUSE LARGE B CELL LYMPHOMA TIPE NODAL DAN EKSTRANODA
بواسطة: , Rodlijatul Machfudzoh, وآخرون
منشور في: (2012)

On Feature Selection and Rule Extraction for High Dimensional Data: A Case of Diffuse Large B-Cell Lymphomas Microarrays Classification
بواسطة: Narissara Eiamkanitchat, وآخرون
منشور في: (2018)

On Feature Selection and Rule Extraction for High Dimensional Data: A Case of Diffuse Large B-Cell Lymphomas Microarrays Classification
بواسطة: Narissara Eiamkanitchat, وآخرون
منشور في: (2018)